We believe this site might serve you best:

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

CytoTox-Fluor™ Cytotoxicity Assay

G9260-5974CA

A Fluorescent Assay to Measure the Relative Number of Dead Cells in Culture

  • Single-reagent-addition, homogeneous assay
  • Amenable to multiplexing with other luminescent cell-based assays

Size

Catalog number selected: G9260

$ 120.00 Your price: Log In

Add to Helix Add to Helix Add to Helix
CytoTox-Fluor™ Cytotoxicity Assay
10ml
$ 120.00
Your price: Log In
Change Configuration

The CytoTox-Fluor™ Cytotoxicity Assay is a single-reagent-addition, homogeneous, fluorescent assay that measures the relative number of dead cells in cell populations. The assay measures a distinct protease activity associated with cytotoxicity and uses a fluorogenic peptide substrate (bis-alanyl-alanyl-phenylanlanyl-rhodamine 110; bis-AAF-R110) to measure "dead-cell activity," which has been released from cells that have lost membrane integrity. The bis-AAF-R110 substrate cannot cross the intact membrane of live cells and therefore gives no signal from live cells. The assay is designed to accommodate downstream multiplexing with several Promega luminescent assays or spectrally distinct fluorescent assay methods, such as assays to measure caspase activation, reporter gene expression or orthogonal measures of viability.

Features and Benefits

  • Homogeneous, "add-mix-measure" protocol eliminates parallel plate processing and reduces cell culture costs.
  • Multiplex the CytoTox-Fluor™ Assay with several Promega luminescent cell-based assays and get more data from every well.
  • Data normalization for dead-cell number makes results more comparable well-to-well, plate-to-plate, day-to-day.
  • Reduce assay variability and avoid the cumulative error associated with multistep protocols.
Notes

G9260 contains sufficient reagents for 100 assays at 100μl/assay in a 96-well format or 400 assays at 25μl/assay in a 384-well format. G9261 contains sufficient reagents for 500 assays at 100μl/assay in a 96-well format or 2,000 assays at 25μl/assay in 384-well format. G9262 contains sufficient reagents for 1,000 assays at 100μl/assay in a 96-well format or 4,000 assays at 25μl/assay in a 384-well format.

Protocols

Specifications

You are viewing: G9260 Change Configuration

What's in the box?

Item Part # Size

bis-AAF-R110 Substrate

G609A 1 × 10μl

Assay Buffer

G610A 1 × 10ml

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Patents and Disclaimers

Patent Pending.

Specifications

You are viewing: G9261 Change Configuration

What's in the box?

Item Part # Size

bis-AAF-R110 Substrate

G609A 5 × 10μl

Assay Buffer

G610A 5 × 10ml

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Patents and Disclaimers

Patent Pending.

Specifications

You are viewing: G9262 Change Configuration

What's in the box?

Item Part # Size

bis-AAF-R110 Substrate

G609B 2 × 50μl

Assay Buffer

G610B 2 × 50ml

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Patents and Disclaimers

Patent Pending.

Resources

workflow-background

Small Molecule Drug Discovery Workflow

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom